BioCentury
ARTICLE | Clinical News

A/H5N1 Avian Influenza Vaccine: Phase I data

October 22, 2012 7:00 AM UTC

Top-line data from a pair of single-blind, placebo-controlled, dose-ranging, U.S. Phase I trials in a total of 666 healthy volunteers aged 18-49 showed that 2 intramuscular injections of Novavax's A/H...